Taking a Stand for Patients
Who We Are
The Alliance for Transparent & Affordable Prescriptions (ATAP) is a coalition of patient and provider organizations functioning at both the state and national level who have joined together to address pharmacy benefit managers (PBMs) and their impact on prescription drug costs and patient access to affordable treatment.
ATAP thanks the Administration for beginning to correct the perverse incentives in our drug supply chain that have caused sharply increasing list prices and ever-climbing out-of-pocket burdens for patients. We support elimination of the antikickback safe harbor for rebate payments from pharmaceutical manufacturers to PBMs. We also encourage the Administration’s vigilance to ensure that arrangements mimicking rebates do not crop up in their place. ATAP supports allowing manufacturers to provide discounts directly to patients at the point-of-sale and notes that this reform will remove barriers to manufacturers lowering drug prices.
The US Senate Finance Committee is upping the ante on the issue of drug pricing with yet another hearing — this time with pharmacy benefit managers.
